UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 2, 2006
LYONDELL CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
| | |
1-10145 | | 95-4160558 |
(Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
1221 McKinney Street, Suite 700, Houston, Texas | | 77010 |
(Address of principal executive offices) | | (Zip Code) |
(713) 652-7200
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events
On October 3, 2006, Lyondell Chemical Company (“Lyondell”) announced the completion of its cash tender offer for its 9.625%, Series A, Senior Secured Notes due 2007 (“Notes”). The tender offer expired at 12:00 midnight ET on Monday, Oct. 2, 2006, with approximately $762 million in aggregate principal amount of Notes tendered and accepted for purchase, representing approximately 90% of outstanding Notes.
On October 6, 2006, Lyondell called the remaining $87.05 million of the Notes. The Notes will be redeemed and the redemption price paid on November 6, 2006. The redemption price will be determined three business days prior to November 6, 2006 at the make-whole price, as defined in the indenture governing the Notes.
The press releases are being filed with this Current Report on Form 8-K as Exhibits 99.1 and 99.2.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
| | |
99.1 | | Press Release |
| |
99.2 | | Press Release |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
LYONDELL CHEMICAL COMPANY |
| |
By: | | /s/ Kerry A. Galvin |
Name: | | Kerry A. Galvin |
Title: | | Senior Vice President and General Counsel |
Date: October 6, 2006
INDEX TO EXHIBITS
| | |
Exhibit Number | | Description |
99.1 | | Press Release |
| |
99.2 | | Press Release |